Jaguar Health issues 547,898 shares to cut $5.05M of 2025 Streeterville note

Jaguar Health, Inc.

• Exchanged 547,898 common shares for $5,049,909 reduction in $10.81M secured note to Streeterville Capital.
• Shares issued under Section 3(a)(9); no cash paid, shares to become free-trading after Rule 144 holding period tacking.
• Post-exchange share count ~1,281,867; issuance adds ~74.6% to prior outstanding stock.
• Note reduction represents ~47% of original principal; remaining balance continues under existing terms.
• CEO Lisa Conte signed; Streeterville receives unrestricted shares via DWAC delivery.